A NEW PARADIGM FOR THE TREATMENT OF OVARIAN CANCER: THE USE OF EPIGENETIC THERAPY TO SENSITIZE PATIENTS TO IMMUNOTHERAPY AND CHEMOTHERAPY

$3,548,150FY2014Department of the ArmyDOD

The Johns Hopkins University

Investigators